Literature DB >> 21942412

Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging.

Thomas E Fehniger1, Akos Végvári, Melinda Rezeli, Kaiu Prikk, Peeter Ross, Magnus Dahlbäck, Goutham Edula, Ruth Sepper, György Marko-Varga.   

Abstract

Drug therapy is often directed to specific organ and tissue compartments where the mode of action of the compound affects specifically targeted biological processes. However, the direct measurement of drug uptake in terms of a time kinetic and concentrations attained at the local sites has not been readily available as a clinical index for most drugs. A proof-of-principle study was conducted to test the utility of applying matrix-assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI) to demonstrate the qualitative distribution pattern of a locally administered drug within tissue sites of targeted action. Here we have measured the occurrence of an inhaled bronchodilator, the muscarinic receptor antagonist ipratropium, within human bronchial biopsies obtained by fiber optic bronchoscopy shortly after dosing exposure. Cryo-preserved biopsy samples from five subjects being evaluated for airway obstruction or potential tumor development were prepared as thin frozen sections. Samples coated with a MALDI matrix were analyzed by a MALDI LTQ Orbitrap XL mass spectrometer at large (100 μm) and small (30 μm) raster sizes. Our results demonstrate that ipratropium is rapidly absorbed into the airway wall. Ipratropium parent ion (m/z 332.332) and daughter ions (m/z 166.2 and 290.2) were coincidently partitioned within submucosal spaces containing targeted airway smooth muscle in four out of five subjects. The signal intensity of ipratropium fragment ions provided estimates that local drug concentrations between 3 and 80 nM were achieved within the airway wall. To our knowledge, this is the first reported study in applying MALDI-MSI to demonstrate the localization of a drug administered at therapeutic levels. The study highlights the potential benefit of MALDI-MSI to provide important measurements of drug efficacy in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21942412     DOI: 10.1021/ac2014349

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  22 in total

1.  Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.

Authors:  S Torok; A Vegvari; M Rezeli; T E Fehniger; J Tovari; S Paku; V Laszlo; B Hegedus; A Rozsas; B Dome; G Marko-Varga
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization.

Authors:  Mark T Bokhart; Elias Rosen; Corbin Thompson; Craig Sykes; Angela D M Kashuba; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2014-10-16       Impact factor: 4.142

Review 3.  Spatially resolved absolute quantitation in thin tissue by mass spectrometry.

Authors:  Vilmos Kertesz; John F Cahill
Journal:  Anal Bioanal Chem       Date:  2021-04       Impact factor: 4.142

4.  Assessing drug and metabolite detection in liver tissue by UV-MALDI and IR-MALDESI mass spectrometry imaging coupled to FT-ICR MS.

Authors:  Jeremy A Barry; M Reid Groseclose; Guillaume Robichaud; Stephen Castellino; David C Muddiman
Journal:  Int J Mass Spectrom       Date:  2015-02-01       Impact factor: 1.986

5.  Absolute Quantification of Rifampicin by MALDI Imaging Mass Spectrometry Using Multiple TOF/TOF Events in a Single Laser Shot.

Authors:  Boone M Prentice; Chad W Chumbley; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-21       Impact factor: 3.109

6.  Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay.

Authors:  Jeremy A Barry; Guillaume Robichaud; Mark T Bokhart; Corbin Thompson; Craig Sykes; Angela D M Kashuba; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2014-04-18       Impact factor: 3.109

Review 7.  Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.

Authors:  Jeremy L Norris; Richard M Caprioli
Journal:  Chem Rev       Date:  2013-02-11       Impact factor: 60.622

8.  Absolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues.

Authors:  Chad W Chumbley; Michelle L Reyzer; Jamie L Allen; Gwendolyn A Marriner; Laura E Via; Clifton E Barry; Richard M Caprioli
Journal:  Anal Chem       Date:  2016-02-05       Impact factor: 6.986

9.  Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry.

Authors:  David A Pirman; Ekem Efuet; Xiao-Ping Ding; Yong Pan; Lin Tan; Susan M Fischer; Raymond N DuBois; Peiying Yang
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

10.  The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).

Authors:  Xiaoming Chen; Roland Andersson; William Cs Cho; David Christiani; Richard Coico; Jeffery Drazen; Markus Ege; Thomas Fehniger; Hongwei Gao; Kunlin Jin; Michael N Liebman; Elena Lopez; Giuseppe Marraro; Gyorgy Marko-Varga; Francesco M Marincola; Laurentiu M Popescu; Claudio Spada; Aamir Shahzad; Ena Wang; Wei Wang; Xiangdong Wang; Yong-Xiao Wang; Jinglin Xia; Jia Qu
Journal:  Clin Transl Med       Date:  2012-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.